A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Online
Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of unknown origin.
Several professionals said the popularity for retatrutide could be connected to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.
Service Response and Content Removal
According to the social media company, the platform has taken down problematic content and prohibited associated hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at residence.
Within moments of joining one community, a vendor posted WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.
Product Information and Pricing
Within these groups, messages show black plastic parcels with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting substances they cannot confirm. Even if the research behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to potentially significant medical dangers”.
